Matches in Wikidata for { <http://www.wikidata.org/entity/Q92441027> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q92441027 description "article scientifique publié en 2019" @default.
- Q92441027 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q92441027 description "scientific article published on 05 August 2019" @default.
- Q92441027 description "wetenschappelijk artikel" @default.
- Q92441027 description "наукова стаття, опублікована 5 серпня 2019" @default.
- Q92441027 name "Ruxolitinib combined with chemotherapy can eradicate chemorefractory central nervous system acute lymphoblastic leukaemia" @default.
- Q92441027 name "Ruxolitinib combined with chemotherapy can eradicate chemorefractory central nervous system acute lymphoblastic leukaemia" @default.
- Q92441027 type Item @default.
- Q92441027 label "Ruxolitinib combined with chemotherapy can eradicate chemorefractory central nervous system acute lymphoblastic leukaemia" @default.
- Q92441027 label "Ruxolitinib combined with chemotherapy can eradicate chemorefractory central nervous system acute lymphoblastic leukaemia" @default.
- Q92441027 prefLabel "Ruxolitinib combined with chemotherapy can eradicate chemorefractory central nervous system acute lymphoblastic leukaemia" @default.
- Q92441027 prefLabel "Ruxolitinib combined with chemotherapy can eradicate chemorefractory central nervous system acute lymphoblastic leukaemia" @default.
- Q92441027 P1433 Q92441027-F79AF146-C25C-4C3A-B081-404419EED437 @default.
- Q92441027 P1476 Q92441027-42AD2986-2EDE-41F1-A677-6EC72E1DB02A @default.
- Q92441027 P2093 Q92441027-8B918FA6-9DE3-44ED-9D49-F2732AFF7515 @default.
- Q92441027 P2093 Q92441027-D0F79B8D-6479-4551-9140-1D77304A27FC @default.
- Q92441027 P2093 Q92441027-D69C4FFC-0414-469A-91F5-ACEE0A44FFAB @default.
- Q92441027 P304 Q92441027-4873048A-0FF4-40FA-A7E8-3852A0EAD23E @default.
- Q92441027 P31 Q92441027-42477C99-C7C3-4B0B-8461-75F0E2E96066 @default.
- Q92441027 P356 Q92441027-03837CD5-546B-448A-997F-F6733B65093C @default.
- Q92441027 P433 Q92441027-FD74C1C8-E0EB-447E-A280-B4280A0D9BA9 @default.
- Q92441027 P478 Q92441027-6BEFF9E1-6FC3-4521-B57E-24826E8D0735 @default.
- Q92441027 P50 Q92441027-C0DC7500-0CD8-4A8C-AAF3-F90B15B68343 @default.
- Q92441027 P50 Q92441027-F36C9C6F-A177-45B3-9433-6FE8427260AF @default.
- Q92441027 P577 Q92441027-FB968FA7-F481-4937-B7D0-DFD233869096 @default.
- Q92441027 P698 Q92441027-29A0FF07-F198-476E-9968-73CBFC3AE7F6 @default.
- Q92441027 P921 Q92441027-476DBECC-9B91-42B7-AFFB-9DB392F04093 @default.
- Q92441027 P356 BJH.16142 @default.
- Q92441027 P698 31385290 @default.
- Q92441027 P1433 Q4970200 @default.
- Q92441027 P1476 "Ruxolitinib combined with chemotherapy can eradicate chemorefractory central nervous system acute lymphoblastic leukaemia" @default.
- Q92441027 P2093 "Daniel J Weisdorf" @default.
- Q92441027 P2093 "Justin Wasko" @default.
- Q92441027 P2093 "Maryam Ebadi" @default.
- Q92441027 P304 "e24-e27" @default.
- Q92441027 P31 Q13442814 @default.
- Q92441027 P356 "10.1111/BJH.16142" @default.
- Q92441027 P433 "1" @default.
- Q92441027 P478 "187" @default.
- Q92441027 P50 Q41721610 @default.
- Q92441027 P50 Q87713608 @default.
- Q92441027 P577 "2019-08-05T00:00:00Z" @default.
- Q92441027 P698 "31385290" @default.
- Q92441027 P921 Q7383611 @default.